Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanine nucleotide-binding protein G(s) subunit alpha (Gs alpha), encoded by the GNAS complex locus, is a critical heterotrimeric G-protein subunit that acts as a molecular switch in signal transduction pathways. Upon activation by ligand-bound G protein-coupled receptors (GPCRs), Gs alpha exchanges GDP for GTP, dissociates from the G beta-gamma dimer, and directly stimulates adenylyl cyclase, leading to an increase in intracellular cyclic AMP (cAMP) and subsequent activation of protein kinase A (PKA). This pathway regulates numerous physiological processes, including endocrine hormone signaling, metabolism, and cell proliferation.
Activating somatic mutations in GNAS (often referred to as the gsp oncogene) lead to constitutive cAMP signaling and are associated with McCune-Albright syndrome, fibrous dysplasia, and various tumors, such as pituitary adenomas and appendiceal mucinous neoplasms. Conversely, inactivating mutations cause Albright's hereditary osteodystrophy and pseudohypoparathyroidism. While Gs alpha has historically been considered difficult to drug directly, research tools and investigational agents like the selective antagonist NF449 and bacterial toxins like cholera toxin (which ADP-ribosylates Gs alpha to keep it active) are used to modulate its function. Additionally, downstream or parallel pathways in GNAS-mutant cancers are being targeted clinically with drugs like the CDK4/6 inhibitor palbociclib.
Direct inhibition of Gs alpha subunit activation, ADP-ribosylation of Gs alpha subunit leading to constitutive activation, and inhibition of GDP-to-GTP exchange
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide-binding protein G(s) subunit alpha (GNAS).